This site contains promotional information intended only for healthcare professionals resident in the United Kingdom
Menu
Close
Example of description text sitting alongside header
Example of description text sitting alongside header
Menu
Close
Example of description text sitting alongside header
Example of description text sitting alongside header
Menu
Close
Adverse event reporting can be found at the bottom of the page
Menu
Close
ABRYSVO®▼(Respiratory Syncytial Virus Vaccine [bivalent, recombinant]) Prescribing Information can be found here.
Understand how RSV (using influenza as a comparator) and the serious consequences for certain populations including young infants and older adults.2,3,4
One of the approximately 64 million acute respiratory infections that occur each year across the globe.5
Although it gets less attention than influenza, RSV is highly contagious and can be spread by asymptomatic carriers.2,3,6
Learn more about how long RSV can survive on different surfaces, the incubation period, symptom presentation and the occurance of viral shedding with Dr Openshaw, Dr Englund and Dr Walsh.3,7
The RSV Experts share about the fleeting natural immunity to RSV and the commonality of reinfection, with a focus on why infants and older adults are more susceptible to serious outcomes of an RSV infection.4
They expand on differing immune responses and physical characteristics in these populations to explain this increased susceptibility.3,4
The hidden annual epidemic with ~64 million global cases each year.5
Hear more from the experts...
Find out how this affects global healthcare systems and hospitalisation of patients in the UK.
Symptoms of an RSV infection can vary widely and are most severe at the extremes of age.4,8
Useful Resources
Discover how to protect your patients with our RSV vaccine for both maternal and older adult indications. eModules now available.
A guide to help you make the most out of your next maternal immunisation conversation.
References:
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search
for MHRA Yellow Card in Google Play or Apple App Store
Adverse events should also be reported to Pfizer Medical Information on 01304 616161
To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.
This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc
This website is brought to you by Pfizer Limited, a company registered in England
and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ
Copyright © 2024 Pfizer Limited. All rights reserved.
VAT registration number GB201048427
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-UNP-GBR-7812. January 2024